viernes, 21 de enero de 2011

Aqueous extract of Carica papaya leaves exhibits anti-tumor activity and immunomodulatory effects


Journal of Ethnopharmacology 127 (2010) 760–767
Contents lists available at ScienceDirect
Journal of Ethnopharmacology
journal homepage: www.elsevier.com/locate/jethpharm
Aqueous extract of Carica papaya leaves exhibits anti-tumor activity and
immunomodulatory effects
Noriko Otsukia,1, Nam H. Dangb,1, Emi Kumagaia, Akira Kondoc, Satoshi Iwataa, Chikao Morimotoa,d,
a Division of Clinical Immunology, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Japan
b Division of Hematology/Oncology, The University of Florida, Gainesville, FL, USA
c Kondo Hospital, 1-6-25, Nishishinhama, Tokushima, Tokushima 770-8008, Japan
d Department of Rheumatology and Allergy, Research Hospital, The Institute of Medical Science, The University of Tokyo, Japan
a b s t r a c t
Aim of the study: Various parts of Carica papaya Linn. (CP) have been traditionally used as ethnomedicine
for a number of disorders, including cancer. There have been anecdotes of patients with advanced cancers
achieving remission following consumption of tea extract made from CP leaves. However, the precise
cellular mechanism of action of CP tea extracts remains unclear. The aim of the present study is to
examine the effect of aqueous-extracted CP leaf fraction on the growth of various tumor cell lines and
on the anti-tumor effect of human lymphocytes. In addition, we attempted to identify the functional
molecular weight fraction in the CP leaf extract.
Materials and methods: The effect of CP extract on the proliferative responses of tumor cell lines and
human peripheral blood mononuclear cells (PBMC), and cytotoxic activities of PBMC were assessed by
[3H]-thymidine incorporation. Flow cytometric analysis and measurement of caspase-3/7 activities were
performed to confirm the induction of apoptosis on tumor cells. Cytokine productions by PBMC were
measured by ELISA. Gene profiling of the effect of CP extract treatment was performed by microarray
analysis and real-time RT-PCR.
Results: We observed significant growth inhibitory activity of the CP extract on tumor cell lines. In PBMC,
the production of IL-2 and IL-4 was reduced following the addition of CP extract, whereas that of IL-
12p40, IL-12p70, IFN-_ and TNF-_ was enhanced without growth inhibition. In addition, cytotoxicity of
activated PBMC against K562 was enhanced by the addition of CP extract. Moreover, microarray analyses
showed that the expression of 23 immunomodulatory genes, classified by gene ontology analysis, was
enhanced by the addition of CP extract. In this regard, CCL2, CCL7, CCL8 and SERPINB2 were representative
of these upregulated genes, and thus may serve as index markers of the immunomodulatory effects of
CP extract. Finally, we identified the active components of CP extract, which inhibits tumor cell growth
and stimulates anti-tumor effects, to be the fraction with M.W. less than 1000.
Conclusion: Since Carica papaya leaf extract can mediate a Th1 type shift in human immune system,
our results suggest that the CP leaf extract may potentially provide the means for the treatment and
prevention of selected human diseases such as cancer, various allergic disorders, and may also serve as
immunoadjuvant for vaccine therapy.
© 2009 Elsevier Ireland Ltd. All rights reserved.


Para acceder al artículo completo, pincha el siguiente link:
http://ifile.it/8rae1yi

Obama Adds to Emphasis on Business With Adviser Choice


Obama Adds to Emphasis on Business With Adviser Choice

Drew Angerer/The New York Times
President Obama with Jeffrey R. Immelt, the chairman and chief executive of General Electric, on Friday at G.E. headquarters in Schenectady, N.Y.
SCHENECTADY, N.Y. — President Obama, sending another strong signal that he intends to make his White House more business-friendly, traveled to this industrial city on Friday to appoint a prominent corporate executive as his chief outside economic adviser, and to spotlight his efforts on job creation, in advance of next week’sState of the Union address.

Related in Opinion

Drew Angerer/The New York Times
Gov. Andrew M. Cuomo of New York greeted President Obama as he arrived in Albany on Friday.
Charles Dharapak/Associated Press
General Electric’s Jeffrey Immelt with President Obama at a roundtable discussion with business leaders in Mumbai, India in November.
Joshua Roberts/Bloomberg News
Paul Volcker stepped down as the chairman of President Obama’s Economic Recovery Advisory Board.

Here in the birthplace of General Electric, where the company’s historic brick edifice and iconic neon-script logo loom over downtown, Mr. Obama turned to Jeffrey R. Immelt, the company’s chairman and chief executive, to run his outside panel of economic advisers. Mr. Immelt succeeds Paul A. Volcker, the former Federal Reserve chairman, who is stepping down.
The selection of Mr. Immelt, who was by Mr. Obama’s side during his trip to India last year and again this week during the visit of President Hu Jintao of China, is the latest in a string of pro-business steps the president has taken. He has installed William Daley, a former JPMorgan Chaseexecutive, as his chief of staff; has scheduled a major speech to the U.S. Chamber of Commerce next month; and ordered federal agencies this week to review regulations with an eye toward eliminating some.
Taken together, the moves amount to a carefully choreographed shift in strategy for the White House, both substantively and on the public relations front, as Mr. Obama makes the case to the nation that the United States has moved past economic crisis mode and is entering ‘’a new phase of our recovery” that demands an emphasis on job creation.
As he moves into the second half of his term and lays the foundation for his 2012 re-election campaign, Mr. Obama will try to frame the national conversation on the economy around this crisis-to-job-creation narrative. Republicans, who have spent the first weeks of the new Congress talking about repealing Mr. Obama’s health care law, have given the president an opening to do so. Here in Schenectady, Mr. Obama seized the opportunity.
“The past two years were about pulling our economy back from the brink,” Mr. Obama said, standing before the backdrop of a huge generator in a well-lighted plant, with a giant American flag hanging from the ceiling. “The next two years, our job now, is putting our economy into overdrive.”
The president went on: “Our job is to do everything we can to ensure that business can take root and folks can find good jobs and America is leading out global competition that will define our success in the 21st century.”
The appointment of Mr. Immelt is not without complications for the president. G.E. has countless regulatory matters now before federal agencies, on subjects ranging from television mergers to environmental cleanup. Having the chief executive of such a company advising the White House on job creation at a time when Mr. Obama is assuming a more deregulatory posture could generate criticism for the president, who came to Washington vowing to reduce the influence of lobbyists and special interests.
Mr. Immelt will be chairman of the Council on Jobs and Competitiveness that Mr. Obama intends to create by executive order. In a statement issued shortly after midnight, Mr. Obama said he wanted the council to “focus its work on finding new ways to encourage the private sector to hire and invest in American competitiveness.”
The council will be a reconfigured version of the board Mr. Volcker led, the President’s Economic Recovery Advisory Board. That body, created by Mr. Obama when he took office in the thick of the worst economic crisis since the Great Depression, is set to expire on Feb. 6.
Asked about his new role during a conference call about G.E.’s latest earnings report on Friday morning, Mr. Immelt said that the advisory position would give him a chance to contribute to issues in the broader economy, with a focus on competitiveness and jobs. “I am honored to serve,” he said.
Mr. Immelt said that his commitment to G.E. would not change. “This is my passion,” he said of the company. “I am committed. I am a hard worker. I am focused on the company.”
Though G.E. moved its headquarters away from Schenectady long ago, the city remains home to G.E.’s largest energy division, and the company’s plants here will build the steam turbines ordered by Reliance Power of India in a $750 million deal announced when Mr. Obama and Mr. Immelt were in India last November. G.E. reported early on Friday that it had earned $4.5 billion in the fourth quarter of 2010 and $11.6 billion for the full year, exceeding Wall Street analysts’ expectations.
Mr. Immelt mentioned his impending appointment in an opinion article published in The Washington Post on Friday. “The president and I are committed to a candid and full dialogue among business, labor and government to help ensure that the United States has the most competitive and innovative economy in the world,” he said in the article. “My hope is that the council will be a sounding board for ideas and a catalyst for action on jobs and competitiveness. It will include small and large businesses, labor, economists and government.”
Christine Hauser contributed reporting from New York
.

Nuevas Guías de atención para enfermos en la región de las Américas


Nuevas Guías de atención para enfermos en la región de las Américas

PDFImprimirE-Mail
Bolivia, 3 de Diciembre de 2010. (Oficina de Información Pública OPS/OMS Bolivia) El dengue es una infección transmitida por mosquitos que en los últimos decenios se ha convertido en un importante problema de salud pública internacional. Se caracteriza por las diferentes presentaciones clínicas que van desde estados benignos hasta una evolución clínica grave y desenlaces que causan la muerte.
La OPS/OMS con sus Estados Miembros han realizado esfuerzos para contener y mitigar el impacto de las epidemias. Es así que en reuniones realizadas en La Habana – Cuba y Kuala Lumpur – Malasia, se vio la necesidad de revisar los aspectos relacionados con el tratamiento y por ende la actualización de las guías clínicas de la OMS. Los protocolos que se manejaban utilizaban criterios clínicos rígidos que se apoyaban fundamentalmente en los exámenes de laboratorio, los que provocaban que la clasificación del dengue se la obtenga solo al final de la enfermedad, lo cual ayuda poco al tratamiento exitoso del paciente. Esta evidencia impulso a la investigación de nuevos elementos científicos de diagnostico, tratamiento y clasificación de los pacientes con dengue, así en diciembre de 2009, la OMS publicó una actualización de las “Guías de diagnóstico, tratamiento, prevención y control del dengue”.
En la Región de las Américas, el Programa Regional de Dengue de la OPS/OMS, a través del Grupo Técnico Internacional de Dengue (GTI-Dengue) convocó a una reunión de expertos sobre el tema para realizar una adecuación y reajuste a las guías de la OMS para el continente Americano.
Ese esfuerzo se encuentra plasmado en el manual: “DENGUE: Guía de atención para enfermos en la región de las Américas” que está diseñada para ser aplicada desde la Atención Primaria de Salud y evita apoyarse en tecnologías de difícil aplicación en lugares con limitados recursos.
Esta guía, repasa los aspectos indispensables que se deben tener en cuenta en cada fase de la enfermedad, incluyendo el manejo de las formas graves en el nivel de atención hospitalario.
 

Books Update



The New York Times

January 21, 2011

Books Update



On the Cover of Sunday's Book Review

'Examined Lives: From Socrates to Nietzsche'

By JAMES MILLER
Reviewed by SARAH BAKEWELL
James Miller argues that philosophers' willingness to reflect on their own petty failings makes their lives more, not less, worth studying.

'All Things Shining: Reading the Western Classics to Find Meaning in a Secular Age'

By HUBERT DREYFUS and SEAN DORRANCE KELLY
Reviewed by SUSAN NEIMAN
Two eminent philosophy professors take aim at contemporary nihilism in this idiosyncratic tour of the classics.

'Late for Tea at the Deer Palace'

By TAMARA CHALABI
Reviewed by LINDA ROBINSON
Ahmad Chalabi's daughter offers an absorbing social history of Iraq through her family story.

'Cinderella Ate My Daughter'

By PEGGY ORENSTEIN
Reviewed by ANNIE MURPHY PAUL
A tour of the hyper-feminine, commercialized world of young girls.

'A Strange Stirring'

By STEPHANIE COONTZ
Reviewed by REBECCA TRAISTER
The social historian Stephanie Coontz re-evaluates "The Feminine Mystique" and its author, Betty Friedan.

'Crime: Stories'

By FERDINAND VON SCHIRACH
Reviewed by OLEN STEINHAUER
A story collection inspired by true stories of German jurisprudence.
Great elder: Leo Tolstoy.

'Lastingness: The Art of Old Age'

By NICHOLAS DELBANCO
Reviewed by BROOKE ALLEN
Nicholas Delbanco asks why some artists mature early and run out of steam, while others gain momentum in old age.

'Learning to Die in Miami'

By CARLOS EIRE
Reviewed by LIGAYA MISHAN
This memoir recalls the heady, scary times of an 11-year-old Cuban's introduction to America in the early 1960s.

'Caribou Island'

By DAVID VANN
Reviewed by KEVIN CANTY
In David Vann's first novel, isolation and an Alaskan winter take their toll on a marriage.

'Alone Together'

By SHERRY TURKLE
Reviewed by JONAH LEHRER
Sherry Turkle once saw technology as a tool for playing with identity. Now she fears it is replacing identity.
Kate Pullinger

'The Mistress of Nothing'

By KATE PULLINGER
Reviewed by LISA FUGARD
A novel recreates Lucie Duff Gordon's escape to Egypt and how her Englishness slowly melted away.

'Give Me Your Heart'

By JOYCE CAROL OATES
Reviewed by ANDREA THOMPSON
The women in Joyce Carol Oates's latest collection display a powerful and self-destructive need for love.

Aqueous extract of Carica papaya leaves exhibits anti-tumor activity and immunomodulatory effect




About this Journal
Journal of Ethnopharmacology


Copyright © 2011 Elsevier Ireland Ltd. All rights reserved 







Aqueous extract of Carica papaya leaves exhibits anti-tumor activity and immunomodulatory effects
  Original Research Article
Pages 760-767
Noriko Otsuki, Nam H. Dang, Emi Kumagai, Akira Kondo, Satoshi Iwata, Chikao Morimoto


Graphical abstract

The leaves of Carica papaya have been used as remedy for various disorders, including cancer.In this paper, we demonstrate that the aqueous-extracted fraction of Carica papaya leaf has several in vitro biological effects: (1) anti-proliferative effect on tumor cells, (2) promotion of Th1 type cytokine production, (3) enhancement of cytotoxicity against tumor cells, (4) upregulation of anti-tumor related genes on PBMC, and (5) the active components of Carica papaya extract to be the fraction with M.W. less than 1000.
These findings are the first report that demonstrated anti-tumor effect of the leaves of Carica papaya, and suggested possibility of inducing a shift to Th1 type immune responses.

image